Navigation Links
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
Date:9/4/2007

ming of completion of such trials; filings for regulatory approval in the United States and in the European Union and the timing of such filings as well as the scope of the indications that the Company is seeking approval for with respect to such filings; the potential markets for NGX-4010; the potential efficacy and benefits of NGX-4010; and NeurogesX' plans to commercialize NGX-4010, including with respect to sales force plans and plans to enter into commercial partnerships. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, subsequent analysis of data from NeurogesX' C117 trial may cause the results to be viewed less favorably as compared to NeurogesX' initial analysis of such trial's results; past results of clinical trials may not be indicative of future clinical trials results; NGX-4010 may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; physician or patient reluctance to use NGX-4010, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies and changing standards of care; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; NeurogesX' ability to obtain additional financing; NeurogesX' ability to obtain and maintain future commercial partnerships; and other difficulties or delays in clinical development, obtaining regulatory approval, market acceptance and commercialization of NGX-4010. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

NeurogesX, Inc.

Stephen Ghiglieri

(650) 508-2116

The Ruth Group

Investors / Med
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  ... Affiniti, a new ultrasound system designed to ... demands of increasing patient volumes and cost pressures. Making ... 2014 in Barcelona this ... facing more patients with fewer resources deliver high quality ...
(Date:8/29/2014)... 2014 The clinical and medical insights provided ... between a product,s success or failure. Despite this, many ... targets – and then to coordinate activities and outreach ... upon which successful KOL engagement rests. ... internal inconsistencies in their KOL management systems and are ...
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
Breaking Medicine Technology:Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... N.Y., Oct. 15 Building on the success of ... response to growing interest from emergency care providers across ... Advanced. , The ALS Simulator is a ... of lifesaving skills in medical emergencies including CPR, ACLS, ...
... Ind., Oct. 15 Press Ganey Associates, Inc. today ... (NYSE: HMA ) to help measure and improve ... company started working with HMA on October 1, 2009. ... acute-care hospitals, with approximately 8,000 licensed beds, in non-urban ...
Cached Medicine Technology:New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel 2Press Ganey Partners With Health Management Associates 2
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) ... September, where issues related to claims involving the pain ... Pennsylvania, Bernstein Liebhard LLP reports. , According to ... website, the meeting is scheduled to take place on ... latest of several Tylenol conferences that have taken place ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web hosting companies. ... is here to announce that JustHost, Bluehost and ... 2014. , JustHost ( http://www.justhost.com/track/seohosts ) provides new ... plan. The company’s approach to hosting is to ... and powerful enough for anyone to use. And ...
(Date:9/1/2014)... Daily Gossip reveals in it's review ... that gives members access to thousands of professionally designed ... resource aims to help both people who plan on ... are looking for inspiration in creating one of a ... Now by visiting the official website at: http://www.dailygossip.org/atattoo-me-now-6444 ...
(Date:9/1/2014)... 01, 2014 AttorneyOne.com, a recognized authority ... latest information from the FDA on DePuy Synthes ... announced on August 28, that specific lots of DePuy ... I) as the device may reverse directions after surgery. ... (CMF) Distraction System is an implant used to lengthen ...
(Date:9/1/2014)... Viejo, California (PRWEB) September 01, 2014 Developers ... a new tutorial video for the ProWorld Plugin from Pixel ... Final Cut Pro X can do and users now have ... HDRI images.” Said Christina Austin, CEO of Pixel Film Studios. ... definite game changer.” , Learn how to turn a 2D ...
Breaking Medicine News(10 mins):Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2
... ANA, Calif., April 2, 2008 Grubb &,Ellis Healthcare ... in Lakeland, Fla., Located at 3035, 3037, 3131, ... complex is comprised of four identical buildings. Each,building has ... square feet. Built in 1996 and 1998 on approximately ...
... a,bipartisan compromise brokered by Foreign Affairs Committee Chairman ... to expand the,landmark U.S. effort to combat HIV/AIDS ... millions of lives., Despite efforts by some ... provides, the Tom Lantos and Henry J. Hyde ...
... 2008 Ventas, Inc.,(NYSE: VTR ) ("Ventas" or ... regarding the Company at the Credit Suisse 2008 Global,Real ... 2008 at 2:50 p.m.,Eastern Time., The presentation will ... at http://www.ventasreit.com . Any written materials,accompanying the presentation ...
... Eye Disease Patients Rising, CHICAGO, April 2 ... eye disease and, according to the latest research,from ... that number,is continuing to climb. With more than ... 30 million suffer from leading causes of vision ...
... Speaker Nancy,Pelosi spoke on the House floor this ... and Malaria Act, which provides,$50 billion over five years ... are the Speaker,s remarks:, "I want to commend ... first,piece of legislation to come out of the Foreign ...
... Life-saving Legislation Is Now Ready for Action on the ... following is a,statement by Bernadette A. Toomey, President and ... the U.S. House of,Representatives Energy and Commerce Committee for ... Act (H.R. 1108). We urge the full,House to quickly ...
Cached Medicine News:Health News:Grubb & Ellis Healthcare REIT Acquires Vista Professional Center in Lakeland, Fla. 2Health News:Grubb & Ellis Healthcare REIT Acquires Vista Professional Center in Lakeland, Fla. 3Health News:Grubb & Ellis Healthcare REIT Acquires Vista Professional Center in Lakeland, Fla. 4Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 2Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 3Health News:Eye Disease Continuing to Increase Among Americans 2Health News:Eye Disease Continuing to Increase Among Americans 3Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 2Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 3
Dilator...
Microscopic scissors, curved...
Microscopic needle holder, curved...
... Back discomfort is a complaint ... wear our most comfortable apron. ... weight off the shoulders and ... shoulder pads are standard for ...
Medicine Products: